{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:06:12Z","timestamp":1790949972898,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.cca.2021.07.006","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T05:34:28Z","timestamp":1625722468000},"page":"199-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer"],"prefix":"10.1016","volume":"521","author":[{"given":"Dimitrios P.","family":"Bogdanos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4775-0410","authenticated-orcid":false,"given":"Athanasios","family":"Gkoutzourelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Liaskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Patrikiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7869-6824","authenticated-orcid":false,"given":"Christina","family":"Tsigalou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Saratziotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2312-7218","authenticated-orcid":false,"given":"John","family":"Hajiioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Scheper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazaros I.","family":"Sakkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Papandreou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cca.2021.07.006_b0005","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00296-017-3718-1","article-title":"A review of the role and clinical utility of anti-Ro52\/TRIM21 in systemic autoimmunity","volume":"37","author":"Lee","year":"2017","journal-title":"Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.cca.2021.07.006_b0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/08916934.2012.732131","article-title":"Clinical associations of anti-SSA\/Ro60 and anti-Ro52\/TRIM21 antibodies: Diagnostic utility of their separate detection","volume":"46","author":"Menendez","year":"2013","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.cca.2021.07.006_b0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/jclinpath-2015-203587","article-title":"Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases","volume":"71","author":"Murng","year":"2018","journal-title":"J. Clin. Pathol."},{"issue":"7","key":"10.1016\/j.cca.2021.07.006_b0020","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/08916934.2017.1357699","article-title":"Disease-related autoantibody profile in patients with systemic sclerosis","volume":"50","author":"Liaskos","year":"2017","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.cca.2021.07.006_b0025","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/liv.12658","article-title":"Anti-SLA\/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis","volume":"35","author":"Zachou","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.cca.2021.07.006_b0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cca.2017.10.002","article-title":"An effective algorithm for the serological diagnosis of idiopathic inflammatory myopathies: The key role of anti-Ro52 antibodies","volume":"475","author":"Infantino","year":"2017","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.cca.2021.07.006_b0035","first-page":"686","article-title":"Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjogren's syndrome","volume":"30","author":"Retamozo","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"10.1016\/j.cca.2021.07.006_b0040","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1515\/cclm-2017-0704","article-title":"Detection of autoantibodies to the p200-epitope of SSA\/Ro52 antigen. A comparison of two laboratory assays","volume":"56","author":"Mattia","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1\u20132","key":"10.1016\/j.cca.2021.07.006_b0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2012.01.014","article-title":"The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review","volume":"39","author":"Oke","year":"2012","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.cca.2021.07.006_b0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/kev300","article-title":"Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease","volume":"55","author":"Gunnarsson","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2021.07.006_b0055","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.3389\/fimmu.2018.02835","article-title":"Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis","volume":"9","author":"Gkoutzourelas","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cca.2021.07.006_b0060","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/art.39437","article-title":"Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic Sclerosis","volume":"68","author":"Mavropoulos","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.cca.2021.07.006_b0065","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2017.04.013","article-title":"IL-10-producing regulatory B cells (B10 cells), IL-17+ T cells and autoantibodies in systemic sclerosis","volume":"184","author":"Mavropoulos","year":"2017","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2021.07.006_b0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.cca.2021.07.006_b0075","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.cca.2021.07.006_b0080","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00296-020-04643-z","article-title":"A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies","volume":"40","author":"Gkoutzourelas","year":"2020","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cca.2021.07.006_b0085","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cca.2020.07.037","article-title":"Autoantibodies against specific nuclear antigens are present in psoriatic disease and are diminished by secukinumab","volume":"510","author":"Patrikiou","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2021.07.006_b0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s13075-015-0871-3","article-title":"Serological epitope profile of anti-Ro52-positive patients with systemic autoimmune rheumatic diseases","volume":"17","author":"Infantino","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"15\u201316","key":"10.1016\/j.cca.2021.07.006_b0095","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.cca.2012.03.020","article-title":"Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis","volume":"413","author":"Mytilinaiou","year":"2012","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.cca.2021.07.006_b0100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/CBM-170652","article-title":"Utility of paraneoplastic antigens as biomarkers for surveillance and prediction of recurrence in ovarian cancer","volume":"20","author":"Chatterjee","year":"2017","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.cca.2021.07.006_b0105","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cca.2016.06.006","article-title":"Autoantibody diversity in paraneoplastic syndromes and related disorders: The need for a more guided screening approach","volume":"459","author":"Tebo","year":"2016","journal-title":"Clin. Chim. Acta"},{"issue":"12","key":"10.1016\/j.cca.2021.07.006_b0110","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.it.2017.07.005","article-title":"TRIM21 and the Function of Antibodies inside Cells","volume":"38","author":"Rhodes","year":"2017","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.cca.2021.07.006_b0115","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/15548627.2016.1154254","article-title":"TRIM-directed selective autophagy regulates immune activation","volume":"13","author":"Kimura","year":"2017","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.cca.2021.07.006_b0120","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/imr.12363","article-title":"TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity","volume":"268","author":"Foss","year":"2015","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/j.cca.2021.07.006_b0125","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1084\/jem.20091507","article-title":"Vicious circle: systemic autoreactivity in Ro52\/TRIM21-deficient mice","volume":"206","author":"Bolland","year":"2009","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cca.2021.07.006_b0130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/15384047.2016.1252880","article-title":"TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells","volume":"18","author":"Nguyen","year":"2017","journal-title":"Cancer Biol. Ther."},{"issue":"11","key":"10.1016\/j.cca.2021.07.006_b0135","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1007\/s13277-015-3572-2","article-title":"Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers","volume":"36","author":"Ding","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cca.2021.07.006_b0140","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fimmu.2019.00444","article-title":"Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52\/TRIM21 Antibody Detection in Autoimmune Diseases","volume":"10","author":"Robbins","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cca.2021.07.006_b0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/cei.12058","article-title":"Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjogren's syndrome","volume":"172","author":"Aqrawi","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"7","key":"10.1016\/j.cca.2021.07.006_b0150","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","article-title":"Latest update on the Ro\/SS-A autoantibody system","volume":"8","author":"Schulte-Pelkum","year":"2009","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.cca.2021.07.006_b0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0961203306073135","article-title":"Fine specificity of the Ro\/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun","volume":"16","author":"Popovic","year":"2007","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.cca.2021.07.006_b0160","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1191\/0961203306lu2309oa","article-title":"Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies","volume":"15","author":"Strandberg","year":"2006","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.cca.2021.07.006_b0165","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar1848","article-title":"52-kDa Ro\/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block","volume":"8","author":"Fritsch","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.cca.2021.07.006_b0170","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.61.12.1090","article-title":"Diagnostic associations in a large and consecutively identified population positive for anti-SSA and\/or anti-SSB: the range of associated diseases differs according to the detailed serotype","volume":"61","author":"Peene","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.cca.2021.07.006_b0175","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.4049\/jimmunol.168.11.5876","article-title":"HLA class II influences the immune response and antibody diversification to Ro60\/Sjogren's syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules","volume":"168","author":"Paisansinsup","year":"2002","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cca.2021.07.006_b0180","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1006\/jaut.1999.0333","article-title":"Autoantibodies to La\/SSB in patients with primary Sjogren's syndrome (pSS) are associated with upregulation of La\/SSB mRNA in minor salivary gland biopsies (MSGs)","volume":"13","author":"Tzioufas","year":"1999","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.cca.2021.07.006_b0185","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1084\/jem.189.3.531","article-title":"Immune responses to Ro60 and its peptides in mice. I. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies","volume":"189","author":"Deshmukh","year":"1999","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.cca.2021.07.006_b0190","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.4049\/jimmunol.157.8.3694","article-title":"The immune response to 52-kDa Ro and 60-kDa Ro is linked in experimental autoimmunity","volume":"157","author":"Keech","year":"1996","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cca.2021.07.006_b0195","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2249.1993.tb03436.x","article-title":"Sera from patients with rheumatic diseases recognize different epitope regions on the 52-kD Ro\/SS-A protein","volume":"94","author":"Bozic","year":"1993","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.cca.2021.07.006_b0200","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1515\/cclm-2017-0241","article-title":"Predictive autoimmunity using autoantibodies: screening for anti-nuclear antibodies","volume":"56","author":"Perez","year":"2018","journal-title":"Clin. Chem. Lab. Med."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898121002370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898121002370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:00:47Z","timestamp":1757862047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898121002370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":40,"alternative-id":["S0009898121002370"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2021.07.006","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2021.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}